| Filed On | Filing |
|---|---|
| 06 Oct 2026 |
8-K: Results of Operations and Financial Condition
In connection with its acquisition of Alesta Therapeutics B.V. (Alesta), a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid), which was completed on August 31, 2026, BioMarin Pharmaceutical In... |
| 30 Sep 2026 |
8-K: Entry into a Material Definitive Agreement
On September 24, 2026, BioMarin Pharmaceutical Inc. (BioMarin) entered into a Settlement and License Agreement (the Agreement) with Ascendis Pharma A/S (Ascendis). |
| 15 Sep 2026 |
8-K: Other Events
On September 15, 2026, BioMarin Pharmaceutical Inc. (BioMarin) announced its decision to discontinue development of VOXZOGO for children with Noonan syndrome. BioMarin made this decision after assessing a number of factors, including the... |
| 14 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On September 10, 2026, the Board of Directors (the Board) of BioMarin Pharmaceutical Inc. (the Company) increased the size of the Board from ten to eleven members and appointed Robert Plenge, M.D., Ph.D., to the Board, to be effective Se... |
| 01 Sep 2026 | 8-K: Other Events |
| 31 Aug 2026 | 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure |
| 18 Aug 2026 | 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 04 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders |
| 04 May 2026 | 8-K: Results of Operations and Financial Condition |
| 27 Apr 2026 | 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +2 more |
| 23 Apr 2026 | 8-K: Other Events |
| 16 Mar 2026 | 8-K: Other Events |
| 23 Feb 2026 | 8-K: Results of Operations and Financial Condition |
| 12 Feb 2026 | 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more |
| 29 Jan 2026 | 8-K: Regulation FD Disclosure |
| 26 Jan 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more |
| 12 Jan 2026 | 8-K: Results of Operations and Financial Condition |
| 22 Dec 2025 | 8-K: Other Events |
| 19 Dec 2025 | 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure |
Loading...
